Abstract
Total thyroidectomy (TT) is the standard of care for differentiated thyroid cancer (DTC), but still there is no consensus about the role of routine use of prophylactic central lymph node dissection. The aim of this study was to analyze our results of TT without prophylactic central lymphadenectomy in the treatment of DTC. Clinical records, between January 1998 and December 2005, of 221 patients undergoing TT, without prophylactic central lymph node dissection, were retrospectively evaluated. Two hundred and eleven patients (95.47 %) also underwent radioiodine (RAI) ablation followed by thyroid stimulating hormone (TSH) suppression therapy. In patients with loco-regional lymph nodal recurrence, lateral and central lymph node dissection was performed. The incidence of permanent hypoparathyroidism (iPTH <10 pg/ml) and permanent vocal fold paralysis were, respectively, 0.91 and 0.91 %. After a 9.6 ± 3.5 years mean follow-up, the rate of loco-regional recurrence, with positive cervical lymph nodes, was 3.16 % (7/221 patients). In these cases a lateral and central lymphadenectomy was carried out without significant complications. Our results showed that TT without prophylactic central lymph node dissection, followed by RAI ablation, was associated with low morbidity and low loco-regional recurrence rate, even if the lack of a control group treated with TT plus prophylactic central lymphadenectomy suggests caution against generalization of our assumption. Such last combined procedure could be indicated in high-risk patients, in whom loco-regional recurrence is more frequent. However, given the trend in the literature toward prophylactic lymphadenectomy and the avoidance of RAI treatment, prospective randomized trials should be conducted to better clarify this issue.
Similar content being viewed by others
References
F. Pacini, Changing natural history of differentiated thyroid cancer. Endocrine 42, 229–230 (2012)
L. Pagano, M. Caputo, M.T. Samà, V. Garbaccio, M. Zavattaro, M.G. Mauri, F. Prodam, P. Marzullo, R. Boldorini, G. Valente, G. Aimaretti, Clinical-pathological changes in differentiated thyroid cancer (DTC) over time (1997–2010): data from the University Hospital “Maggiore della Carità” in Novara. Endocrine 42, 382–390 (2012)
D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, S.I. Sherman, R.M. Tuttle, Management guidelines for patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines taskforce. Thyroid 16, 109–142 (2006)
F. Arturi, D. Russo, D. Giuffrida, A. Ippolito, N. Pernotti, R. Vigneti, S. Filetti, Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab 82, 1638–1641 (1997)
A. De Bellis, G. Conzo, G. Cennamo, E. Pane, G. Bellastella, C. Colella, A.D. Dello Iacovo, V.A. Paglionico, A.A. Sinisi, J.R. Wall, A. Bizzarro, A. Bellastella, Time course of Grave’s ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study. Endocrine 4, 320–326 (2011)
L.W. Mattew, P.G. Gauger, G.M. Doherty, Central lymph node dissection in differentiated thyroid cancer. World J Surg 31, 895–904 (2007)
B.M. Sadowski, S.K. Snider, T.C. Lairmore, Routine bilateral central lymph node clearance for papillary thyroid cancer. Surgery 146, 696–703 (2009)
J.A. Pereira, J. Ymeno, J. Miquel, M. Iglesias, A. Munné, J.J. Sancho, A. Sitges-Serra, Nodal yield morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 138, 1095–1100 (2005)
W.T. Shen, L. Orgawa, D. Ruan, I. Suh, Q.Y. Duh, O.H. Clark, Central neck lymph node dissection for papillary thyroid cancer: the reliability of surgeon judgment in predicting which patients will benefit. Surgery 148, 398–403 (2010)
J.F. Henry, L. Gramatica, A. Denizot, A. Kvachenyuk, M. Puccini, T. Defechereux, Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbecks Arch Surg 383, 167–169 (1998)
N. Palestini, A. Borasi, L. Cestino, M. Freddi, C. Odasso, A. Robecchi, Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience. Langenbecks Arch Surg 393, 693–698 (2008)
E.L. Mazzaferri, G.M. Doherty, D.L. Steward, The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid 19, 683–689 (2009)
J.L. Roh, J.M. Kim, C.I. Park, Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis. Ann Surg Oncol 15, 2482–2486 (2008)
K.T. Robbins, G. Clayman, P.A. Levine, J. Medina, R. Sessions, A. Shaha, P. Som, G.T. Wolf, American head and neck society; American academy of otolaryngology–head and neck surgery: neck dissection classification update, revisions proposed by the American head and neck society and the American academy of otolaryngology-head and neck surgery. Arch Otolaryngol Head Neck Surg 128, 751–758 (2002)
D. Pasquali, A. Santoro, B. Bufo, G. Conzo, W.J. Deery, A. Renzullo, G. Accardo, V. Sacco, A. Bellastella, G. Pannone, Upregulation of endocrine gland-derived vascular endothelial growth factor in papillary thyroid cancers displaying infiltrative patterns, lymph node metastases, and BRAF mutation. Thyroid 21, 391–399 (2011)
M. Schlumberger, B. Catargi, I. Borget Pham, D. Deandreis, S. Zerdoud, B. Bridj, S. Bardet, L. Leenardt, D. Bastie, C. Schvartz, P. Vera, O. Morel, D. Benisvy, C. Bournaud, F. Bonichon, C. Dejax, M.E. Toubert, S. Lebouilleux, M. Ricard, E. Benamou, Strategies of radioiodine ablation in patients with low-risk thyroid cancer. N Engl J Med 366, 1663–1673 (2012)
U. Malick, C. Hamer, B. Yap, J. Wadsley, S. Clarke, L. Moss, A. Nicol, P.M. Clark, K. Farnel, R. McCready, J. Smellie, J.A. Franklyn, R. John, C.M. Nutting, K. Newbold, C. Lenon, G. Gerard, A. Abdel-Amid, J. Hardman, E. Macias, T. Roques, S. Whitaker, R. Vijaian, P. Alvarez, S. Beare, S. Forsyth, L. Kadalayil, A. Hackshaw, Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer. N Engl Med 366, 1674–1685 (2012)
L. Wartofsky, D. Van Nostrand, Radioiodine treatment of well-differentiated thyroid cancer. Endocrine 42, 506–513 (2012)
I.D. Hay, W.M. McConahey, J.R. Goellner, Managing patients with papillary thyroid carcinoma:insights gained from the Mayo Clinic’s experience of treating 2512 consecutive patients during 1940 through 2000. Trans Am Clin Climatol Assoc 113, 241–260 (2002)
C.I. Lundgren, P. Hall, P.W. Dickman, J. Zedenius, Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 106, 524–531 (2006)
T. Steinmüller, J. Klupp, N. Rayes, F. Ulrich, S. Jonas, K.J. Gräf, P. Neuhaus, Prognostic factors in patients with differentiated thyroid carcinoma. Eur J Surg 166, 29–33 (2000)
L.E. Tisell, B. Nilsson, J. Molne, G. Hansson, M. Fjalling, S. Jansson, U. Wingren, Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg 20, 854–859 (1996)
S. Noguchi, N. Murakami, H. Yamashita, M. Toda, H. Kawamoto, Papillary thyroid carcinoma: modified radical neck dissection improves prognosis. Arch Surg 133, 276–280 (1998)
R. Cirocchi, C. Boselli, S. Guarino, A. Sanguinetti, S. Trastulli, I. Desiderio, A. Santoro, F. Rondelli, G. Conzo, D. Parmeggiani, G. Noya, G. De Toma, N. Avenia, Total thyroidectomy with ultrasonic dissector for cancer: multicentric experience. World J Surg Oncol 10, 70 (2012). doi:10.1186/1477-7819-10-70
D.B. De van Roy Zuidewijn, I. Songun, J. Kievit, C.J. van de Velde, Complications of thyroid surgery. Ann Surg Oncol 2, 56–60 (1995)
Y.S. Lee, S.W. Kim, S.W. Kim, S.K. Kim, H.S. Kang, E.S. Lee, K.W. Chung, Extent of routine central lymph node dissection with small papillary thyroid carcinoma. World J Surg 31, 1954–1959 (2007)
I.D. Hay, M.E. Hutchinson, T. Gonzalez-Losada, B. McIver, M.E. Reinalda, C.S. Grant, G.B. Thompson, T.J. Sebo, J.R. Goellner, 2008 Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 144, 980–987 (2008)
M. Sywak, L. Conford, P. Roach, P. Stalberg, S. Sidhu, L. Delbridge, Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140, 1000–1007 (2006)
Y.L. Son, H.S. Jeong, C.H. Baek, M.K. Chung, J. Ryu, J.H. Chung, J.K. So, J.Y. Jang, J. Choi, Extent of prophylactic lymph node dissection in the central neck area of the patients with papillary thyroid carcinoma: comparation of limited versus comprehensive lymph node dissection in a 2-year safety study. Ann Surg Oncol 15, 2020–2026 (2008)
D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, F. Pacini, M. Schlumberger, S.I. Sherman, D.L. Steward, R.M. Tuttle, Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19, 1167–1214 (2009)
E.J. Chisholm, E. Kulinskaya, N.S. Tolley, Systematic review and meta-analysis of the adverse effects of thyroidectomy combined with central neck dissection as compared with thyroidectomy alone. The Laryngoscope 119, 1135–1139 (2009)
Y. Ito, C. Tomoda, T. Uruno, Y. Takamura, A. Miya, K. Kobayashi, F. Matsuzuka, K. Kuma, A. Miyauchi, Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg 30, 91–99 (2006)
N. Wada, Q.Y. Duh, K. Surgino, H. Iuasaki, K. Kameyama, T. Mimura, K. Ito, H. Takami, Y. Takanashi, Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann. Surg. 237, 399–407 (2003)
T. Carling, W.D. Long 3rd, R. Udelsman, Controversy surrounding the role for routine central lymph node dissection for differentiated thyroid cancer. Curr. Opin. Oncol. 22, 30–34 (2010)
F. Pacini, M. Schlumberger, H. Dralle, R. Elisei, J.W. Smit, W. Wiersinga, 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur. J. Endocrinol. 154, 787–803 (2006)
G.W. Randolph, Q.Y. Duh, K.S. Heller, V.A. Livolsi, S.J. Mandel, D.L. Steward, R.P. Tufano, Tuttle for the American thyroid association surgical affairs committee’s taskforce on thyroid cancer nodal surgery RM. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid 22, 1144–1152 (2012)
D.S. Ross, 2002 Nonpalpable thyroid nodules-managing an epidemic. J. Clin. Endocrinol. Metab. 87, 1938–1940 (2002)
G.H. Tan, H. Gharib, Thyroid incidentalomas: management approaches to non-palpable nodules discovered incidentally on thyroid imaging. Ann. Intern. Med. 126, 226–231 (1997)
J.L. Roh, J.Y. Park, C. Park II, Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients. Pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann. Surg. 245, 604–610 (2007)
S. Bonnet, D. Hartl, S. Leboulleux, E. Baudin, J.D. Lumbroso, A.A. Ghuzlan, L. Chami, M. Schlumberger, J.P. Travagli, Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J. Clin. Endrocrinol. Metab. 94, 1162–1167 (2009)
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Conzo, G., Pasquali, D., Bellastella, G. et al. Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases. Endocrine 44, 419–425 (2013). https://doi.org/10.1007/s12020-013-9877-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-013-9877-2